TP53 and B-cell chronic lymphocytic leukemia: A recent work has analyzed the circulating EVs in both CLL and RS patients and discovered high levels of miR-19b as predictor of the evolution of drug-resistant CLL toward RS, resulting in down-regulation of TP53 and up-regulation of MKI67, as mechanism of tumor cell proliferation, survival and invasion [80].